Health ❯ Medicine ❯ Pharmaceuticals

Clinical Trials

Weight Loss Treatments Weight Loss Drugs Phase 3 Studies Alzheimer's Disease Obesity Treatments Idiopathic Pulmonary Fibrosis Hereditary Angioedema Drug Development Male Birth Control Patient Data Analysis Efficacy Studies Treatment Development Experimental Treatments Breakthrough Therapy Obesity Medication Atopic Dermatitis Monoclonal Antibodies Weight Reduction Donanemab vs Leqembi Obesity Drugs Cannabis Extracts Zepbound Clinical Trials Semaglutide Trial

AstraZeneca’s COPD Antibody Tozorakimab Succeeds in Two Phase 3 Trials

The IL-33 drug cut COPD flare-ups, hinting at a new class.

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial